Patents by Inventor Hazel B. Breitz
Hazel B. Breitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20130203725Abstract: A method for treatment of small cell lung cancer (SCLC) that does not respond to first-line treatment or that progresses following cessation of first-line organoplatinum chemotherapy is provided that includes the administration of picoplatin, optionally in conjunction with a regimen of best supportive care. Multiple doses of picoplatin can be administered. The picoplatin can also treat SCLC that has metastacized to the brain.Type: ApplicationFiled: March 4, 2011Publication date: August 8, 2013Applicant: Poniard Pharmaceuticals, Inc.Inventors: Hazel B. Breitz, Robert De Jager, Paul L. Weiden
-
Publication number: 20130202690Abstract: The invention provides an encapsulated unit dosage form for picoplatin that is adapted for oral administration of the picoplatin containing a substantially dry powder with about 20 to 55 wt % picoplatin in the physical form of a picoplatin particulate wherein an average picoplatin particle diameter is less than about 10 microns. The picoplatin particles are dispersed within the powder of the formulation which includes a substantially water-soluble, water-dispersible, or water-absorbing carbohydrate and an effective amount of up to about 5 wt % of a lubricant.Type: ApplicationFiled: September 27, 2012Publication date: August 8, 2013Applicant: Poniard Pharmaceuticals, Inc.Inventors: Alistair J. Leigh, Christopher A. Procyshyn, Angelica F. Phillips, Hazel B. Breitz
-
Publication number: 20120156199Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.Type: ApplicationFiled: May 12, 2010Publication date: June 21, 2012Applicant: Poniard Pharmaceuticals, Inc.Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
-
Publication number: 20120122825Abstract: The invention provides a method of treatment of metastatic hormone-refractory prostate cancer involving substantially as concurrent administration of picoplatin and docetaxel. Prednisone may also be administered. Dosages and dosing regimens are provided.Type: ApplicationFiled: May 12, 2010Publication date: May 17, 2012Applicant: Poniard Pharmaceuticals, Inc.Inventors: David A. Karlin MD, Hazel B. Breitz MD, Paul L. Weiden MD, Robert De Jager
-
Patent number: 8178564Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens. Dosages, dosing schedules, and ancillary treatments are described.Type: GrantFiled: February 6, 2009Date of Patent: May 15, 2012Assignee: Poniard Pharmaceuticals, Inc.Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
-
Patent number: 8173686Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.Type: GrantFiled: May 13, 2009Date of Patent: May 8, 2012Assignee: Poniard Pharmaceuticals, Inc.Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
-
Patent number: 8168662Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens. Dosages, dosing schedules, and ancillary treatments are described.Type: GrantFiled: July 23, 2009Date of Patent: May 1, 2012Assignee: Poniard Pharmaceuticals, Inc.Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
-
Patent number: 8168661Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.Type: GrantFiled: May 12, 2009Date of Patent: May 1, 2012Assignee: Poniard Pharmaceuticals, Inc.Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
-
Publication number: 20100260832Abstract: The present invention provides a method to treat ovarian cancer by the administration of effective amounts of picoplatin and doxorubicin.Type: ApplicationFiled: May 17, 2010Publication date: October 14, 2010Applicant: Poniard Pharmaceuticals, Inc.Inventors: Michael S. Perry, Hazel B. Breitz, Cheni Kwok, Robert De Jager
-
Publication number: 20100215727Abstract: Methods for stabilizing aqueous solutions of picoplatin are provided. Such stable, preferably aseptic solutions are particularly useful for preparing unit dosages of picoplatin for oral or intravenous administration, preferably in combination with at least one additional non-platinum anti-cancer agent.Type: ApplicationFiled: December 10, 2009Publication date: August 26, 2010Applicant: Poniard Pharmaceuticals, Inc.Inventors: Alistair J. Leigh, Ronald A. Martell, David A. Karlin, Cheni Kwok, Christopher A. Procyshyn, Hazel B. Breitz, Paul L. Weiden
-
Publication number: 20100178328Abstract: The present invention provides a method to treat ovarian cancer by the administration of effective amounts of picoplatin and pegylated liposomal doxorubicin.Type: ApplicationFiled: December 10, 2009Publication date: July 15, 2010Applicant: Poniard Pharmaceuticals, Inc.Inventors: Ronald A. Martell, David A. Karlin, Hazel B. Breitz, Paul L. Weiden
-
Publication number: 20100062056Abstract: The invention provides an encapsulated unit dosage form for picoplatin that is adapted for oral administration of the picoplatin containing a substantially dry powder with about 20 to 55 wt % picoplatin in the physical form of a picoplatin particulate wherein an average picoplatin particle diameter is less than about 10 microns. The picoplatin particles are dispersed within the powder of the formulation which includes a substantially water-soluble, water-dispersible, or water-absorbing carbohydrate and an effective amount of up to about 5 wt % of a lubricant.Type: ApplicationFiled: August 5, 2009Publication date: March 11, 2010Applicant: Poniard Pharmaceuticals, Inc.Inventors: Alistair J. Leigh, Christopher A. Procyshyn, Angelica Phillips, Hazel B. Breitz
-
Publication number: 20090306034Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.Type: ApplicationFiled: May 13, 2009Publication date: December 10, 2009Applicant: Poniard Pharmaceuticals, Inc.Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
-
Publication number: 20090275549Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.Type: ApplicationFiled: May 12, 2009Publication date: November 5, 2009Applicant: Poniard Pharmaceuticals, Inc.Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
-
Publication number: 20090197854Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens. Dosages, dosing schedules, and ancillary treatments are described.Type: ApplicationFiled: February 6, 2009Publication date: August 6, 2009Applicant: Poniard Pharmaceuticals, Inc.Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden